BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24904088)

  • 1. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.
    Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
    J Am Soc Nephrol; 2014 Nov; 25(11):2459-70. PubMed ID: 24904088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
    Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the Role of the Transcription Factor Tcf21 in the Transdifferentiation of Parietal Epithelial Cells into Podocyte-Like Cells.
    Kliewe F; Kuss AW; Siegerist F; Schröder S; Schordan S; Artelt N; Kindt F; Amann K; Lindenmeyer MT; Endlich K; Endlich N
    Cell Physiol Biochem; 2021 Jun; 55(S4):48-67. PubMed ID: 34148307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.
    Ueno T; Kobayashi N; Nakayama M; Takashima Y; Ohse T; Pastan I; Pippin JW; Shankland SJ; Uesugi N; Matsusaka T; Nagata M
    Kidney Int; 2013 Jun; 83(6):1065-75. PubMed ID: 23447065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated nephropathy: experimental models.
    Avila-Casado C; Fortoul TI; Chugh SS
    Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.
    Gödel M; Hartleben B; Herbach N; Liu S; Zschiedrich S; Lu S; Debreczeni-Mór A; Lindenmeyer MT; Rastaldi MP; Hartleben G; Wiech T; Fornoni A; Nelson RG; Kretzler M; Wanke R; Pavenstädt H; Kerjaschki D; Cohen CD; Hall MN; Rüegg MA; Inoki K; Walz G; Huber TB
    J Clin Invest; 2011 Jun; 121(6):2197-209. PubMed ID: 21606591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor 21 expression in injured podocytes of glomerular diseases.
    Usui J; Yaguchi M; Yamazaki S; Takahashi-Kobayashi M; Kawamura T; Kaneko S; Seshan SV; Ronco P; Yamagata K
    Sci Rep; 2020 Jul; 10(1):11516. PubMed ID: 32661376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
    Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
    Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.
    Schwartzman M; Reginensi A; Wong JS; Basgen JM; Meliambro K; Nicholas SB; D'Agati V; McNeill H; Campbell KN
    J Am Soc Nephrol; 2016 Jan; 27(1):216-26. PubMed ID: 26015453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial
    Luque Y; Lenoir O; Bonnin P; Hardy L; Chipont A; Placier S; Vandermeersch S; Xu-Dubois YC; Robin B; Lazareth H; Souyri M; Guyonnet L; Baudrie V; Camerer E; Rondeau E; Mesnard L; Tharaux PL
    J Am Soc Nephrol; 2017 Dec; 28(12):3563-3578. PubMed ID: 28928136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
    Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
    Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
    Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
    J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
    Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
    Sakamoto K; Ueno T; Kobayashi N; Hara S; Takashima Y; Pastan I; Matsusaka T; Nagata M
    Am J Physiol Renal Physiol; 2014 Jan; 306(1):F98-F104. PubMed ID: 24154691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome Analysis of Isolated Podocytes Reveals Stress Responses in Glomerular Sclerosis.
    Koehler S; Kuczkowski A; Kuehne L; Jüngst C; Hoehne M; Grahammer F; Eddy S; Kretzler M; Beck BB; Höhfeld J; Schermer B; Benzing T; Brinkkoetter PT; Rinschen MM
    J Am Soc Nephrol; 2020 Mar; 31(3):544-559. PubMed ID: 32047005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
    Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
    J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.